Development of a movement-based in vitro screening assay for the identification of new anti-cestodal compounds.
Intestinal cestodes are infecting millions of people and livestock worldwide, but treatment is mainly based on one drug: praziquantel. The identification of new anti-cestodal compounds is hampered by the lack of suitable screening assays. It is difficult, or even impossible, to evaluate drugs agains...
Saved in:
Main Authors: | Dominic Ritler (Author), Reto Rufener (Author), Heinz Sager (Author), Jacques Bouvier (Author), Andrew Hemphill (Author), Britta Lundström-Stadelmann (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2017-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Screening of the Open Source Malaria Box Reveals an Early Lead Compound for the Treatment of Alveolar Echinococcosis.
by: Britta Stadelmann, et al.
Published: (2016) -
Profound activity of the anti-cancer drug bortezomib against Echinococcus multilocularis metacestodes identifies the proteasome as a novel drug target for cestodes.
by: Britta Stadelmann, et al.
Published: (2014) -
Zoonotic larval cestode infections: neglected, neglected tropical diseases?
by: Christine M Budke, et al.
Published: (2009) -
Unique pharmacological properties of serotoninergic G-protein coupled receptors from cestodes.
by: Federico Camicia, et al.
Published: (2018) -
Genetic diversity of the cestode Echinococcus multilocularis in red foxes at a continental scale in Europe.
by: Jenny Knapp, et al.
Published: (2009)